Literature DB >> 23444487

New set of Alzheimer's trials focus on prevention.

Zoë Corbyn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23444487     DOI： 10.1016/s0140-6736(13)60330-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  The end of Alzheimer's disease--from biochemical pharmacology to ecopsychosociology: a personal perspective.

Authors:  Peter J Whitehouse
Journal:  Biochem Pharmacol       Date:  2013-12-01       Impact factor: 5.858

2.  A Potent Multi-functional Neuroprotective Derivative of Tetramethylpyrazine.

Authors:  Hai-Yun Chen; Da-Ping Xu; Guo-Lian Tan; Wei Cai; Gao-Xiao Zhang; Wei Cui; Jin-Zhao Wang; Cheng Long; Ye-Wei Sun; Pei Yu; Karl Wahkeung Tsim; Zai-Jun Zhang; Yi-Fan Han; Yu-Qiang Wang
Journal:  J Mol Neurosci       Date:  2015-05-17       Impact factor: 3.444

3.  Fingolimod affects gene expression profile associated with LPS-induced memory impairment.

Authors:  Rana Omidbakhsh; Banafshe Rajabli; Sanaz Nasoohi; Behzad Khallaghi; Zahurin Mohamed; Murali Naidu; Abolhassan Ahmadiani; Leila Dargahi
Journal:  Exp Brain Res       Date:  2014-08-07       Impact factor: 1.972

4.  Effects of dihydrotestosterone on synaptic plasticity of the hippocampus in mild cognitive impairment male SAMP8 mice.

Authors:  Wensen Pan; Shuo Han; Lin Kang; Sha Li; Juan Du; Huixian Cui
Journal:  Exp Ther Med       Date:  2016-06-21       Impact factor: 2.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.